What your 99214 actually pays: ten years of rates, by payer

The level-4 office visit is the workhorse of behavioral-health medication management. Over a decade its Medicare rate quietly eroded, jumped on a rule change, then fell again. Commercial payers move differently, and some of them are now paying it as a 99213 without telling you.

The code, and why it matters for prescribers

CPT (Current Procedural Terminology) code 99214 is the level-4 established-patient office visit: 30 to 39 minutes of total time, or medical decision-making (MDM) classified as moderate complexity. For a psychiatric mental health nurse practitioner (PMHNP) or psychiatrist running medication management visits, it is the dominant code. Adjust a stimulant dose for an ADHD (attention deficit hyperactivity disorder) patient who had a poor week: that is probably a 99214. Review labs, titrate a mood stabilizer for a bipolar patient mid-episode: 99214. A stable follow-up with no med change might be a 99213, but 99214 is where behavioral-health prescriber revenue concentrates.

Picture a 10-clinician group practice, mostly PMHNPs, each carrying 25 medication management visits a day. That is 250 encounters daily. If 60% are 99214s, the practice bills 150 units of this single code every morning. Every dollar per-unit swing across 150 daily encounters is $150 per day, $37,500 per year. The rate matters.

What Medicare actually paid, year by year

The chart above shows the national non-facility Medicare allowed amount for 99214 from 2015 through 2026. Two forces drive it: the Medicare conversion factor (CF), a single dollar multiplier CMS sets annually, and the relative value units (RVUs) assigned to the code itself.

From 2015 through 2020, the rate was nearly flat in nominal terms, hovering near $129. The CF moved only slightly each year (from $35.80 to $36.09), and the code's total RVUs stayed at approximately 3.59 (work RVU of 1.50 + practice expense + malpractice). Real purchasing power, however, fell against inflation throughout this period.

In 2021, CMS restructured office-based evaluation and management (E/M) codes as part of a "Patients Over Paperwork" overhaul. The work RVU for 99214 jumped from 1.50 to 1.92, a 28% increase. That alone would have pushed the payment up meaningfully, but the budget-neutrality rules that govern the Medicare Physician Fee Schedule (MPFS) required CMS to offset the RVU increases by cutting the CF from $36.09 to $34.89. The net result: a slight increase from $129.56 to $131.20. One hand gave; the other took.

Then came five consecutive years of CF cuts. The conversion factor fell from $34.89 in 2021 to $32.35 in 2025, a cumulative 7.3% drop. Against practice cost inflation over the same stretch, the real squeeze was roughly twice that. The 99214 rate hit its decade low of $121.88 in 2023. Congress passed mid-year patches in 2022 and again in 2025, each one partially reversing a CMS cut, but neither one held into the next calendar year.

2026 broke the streak. The CY 2026 MPFS final rule (CMS-1832-F) set the CF at $33.40, a 3.26% increase. CMS also restructured the practice expense (PE) RVU for non-facility 99214, pushing total RVUs from approximately 3.83 to 4.06. Both factors moved in the same direction for the first time in years, producing an 8.3% single-year jump: from $125.18 to $135.61.

What commercial payers pay

Commercial rates are not public by default. Payers negotiate contracts individually, and most contracts include non-disclosure clauses. What is available comes from three sources: machine-readable files (MRFs) that the No Surprises Act required large payers to publish starting in 2022, state all-payer claims databases (APCDs), and commercial benchmarking services that aggregate claims data at scale.

The table below shows national average commercial rates for 99214, drawn from PayerPrice (which aggregates MRF data, verified June 2026) and compared to the current Medicare benchmark. Read the sourcing column carefully: direct means pulled from MRF aggregation; triangulated means derived from a Medicare percentage multiplier or APCD benchmark.

National averages mask significant variation. A high-volume multi-specialty group in California may have negotiated Cigna rates 25-30% above the national average shown here. A solo PMHNP in a low-density rural market may be below these figures. MRF data aggregates all provider contracts for a payer, not a specialty-specific rate. For BH-specific benchmarks, FAIR Health's FH Medical Price Index (2025 edition) documents that mental and behavioral health codes have lagged commercial market growth by 3.1 percentage points annually since 2019.

Two things stand out in the commercial picture. First, Cigna is the only major payer currently reimbursing above Medicare for 99214. Second, the spread between the highest (Cigna at $144.66) and the lowest major commercial payer (Aetna at $119.38) is $25.28 per visit, or roughly $6,320 per clinician per year at 250 visits a year. Contract negotiations matter enormously at the individual practice level, and the MRF data gives you a defensible benchmark number to bring to those conversations.

The downcoding threat: paying 99214 as 99213

Starting in Q2 2019, UnitedHealthcare stopped denying high-level E/M claims and started adjusting them, a quiet policy change flagged by the American Academy of Family Physicians (AAFP) in their practice management blog. Instead of a denial (which triggers an appeal), UHC began paying what it considered the "appropriate" level and closing the claim. Physicians who did not monitor their remittance advice line by line would not catch it.

By 2022, the practice had spread. Medicare Advantage (MA) plans operated by UHC, Humana, Aetna, and regional BCBS plans began deploying AI-driven claims adjudication tools that flagged high-level E/M visits, particularly 99214 and 99215, for automatic reduction. Cigna formalized this as Policy R49 and applied it explicitly starting October 1, 2025, covering codes 99204, 99205, 99214, 99215, 99244, and 99245. Maryland's insurance administration fined Cigna $80,000 in March 2026 and ordered it to reprocess affected claims, but the systemic practice continues across payers.

The per-visit math is straightforward. Medicare 2026 pays $135.61 for a 99214 and $95.19 for a 99213. The gap is $40.42. For a commercial payer using a 92% Medicare multiplier (roughly UHC's national average), the comparable figures run around $124 versus $88: a $36 gap. In a practice billing 150 level-4 visits a day, a 10% downcode rate costs roughly $540 per day, or $135,000 annually, without a single denial ever being flagged in the practice management system.

The so-what

Three concrete moves for a clinic owner reading this in mid-2026:

• Benchmark your collected rate. For each major payer, pull your average collected amount per 99214 unit from the last 90 days. Compare it to the MRF national averages in the table above. If UHC is paying you $89 per visit when the national MRF average is $124, you are either under-contracted or being systematically downgraded, and you can find out which.
• Audit your code distribution. A medication management panel should have 99214 as the majority code for established patients. If your practice's 99213-to-99214 ratio shifted after October 2025 (when Cigna formalized its downcoding policy) or after any payer contract renewal, investigate. The shift is the signal.
• Capture the 2026 Medicare rate increase. The 8.3% jump from 2025 to 2026 is the largest single-year gain for this code in a decade. If your billed charges for 99214 have not been updated, or if your clearinghouse is still submitting 2025 fee schedule amounts, you are leaving approximately $10 per Medicare visit on the table right now.